ON THE HORI­ZON: BET­TER TESTS

Prima (UK) - - Best Of Health -

The re­search pro­gramme FORECEE (4C), which is funded by The Eve Ap­peal, is look­ing at de­vel­op­ing one smear test to pre­dict risk for four ma­jor women’s can­cers: breast, ovarian, cer­vi­cal and womb. They hope to have the test ready by 2020, en­abling sig­nif­i­cantly more women’s lives to be saved. ‘The test would be at five-year pe­ri­ods and would in­di­cate who should go on for con­fir­ma­tory ge­netic test­ing,’ said Pro­fes­sor Martin Wid­schwendter, head of the depart­ment of women’s cancer at Univer­sity Col­lege London and in­ter­na­tional lead clin­i­cian.

• WANT TO KNOW MORE?

The Eve Ap­peal is the only UK char­ity fund­ing re­search into all five gy­nae can­cers. Visit eveap­peal.org.uk

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.